Dow Jones

39,112.16

-0.76%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

CHIR

Chiron (CHIR)

Chiron (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CHIR

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/06/2006	09:50	PR Newswire (US)	Bayer Diagnostics Receives FDA Approval for First Fully-Automated Human Immunodeficiency Virus (HIV) Antibody Test	NASDAQ:CHIR	Chiron (MM)
19/04/2006	11:11	Business Wire	Chiron Shareholders Approve Novartis Acquisition	NASDAQ:CHIR	Chiron (MM)
12/04/2006	17:54	PR Newswire (US)	Standard & Poor's Announces Changes to U.S. Indices	NASDAQ:CHIR	Chiron (MM)
11/04/2006	19:16	PR Newswire (US)	/C O R R E C T I O N -- NASDAQ/	NASDAQ:CHIR
11/04/2006	18:32	PR Newswire (US)	Akamai Technologies, Inc. to Join the NASDAQ-100 Index Beginning April 20, 2006	NASDAQ:CHIR	Chiron (MM)
11/04/2006	07:00	Business Wire	Chiron Announces Initiation of Phase 1 Trial for CHIR-265 In Melanoma; Clinical Testing of Novel Oncology Compound Begins in Pa	NASDAQ:CHIR	Chiron (MM)
05/04/2006	15:05	Business Wire	Proxy Advisory Services Recommend Shareholders Vote in Favor of Chiron's Amended Merger Agreement with Novartis	NASDAQ:CHIR	Chiron (MM)
03/04/2006	11:22	Business Wire	Chiron Announces Amended Merger Agreement with Novartis; Novartis to Acquire All Outstanding Chiron Shares for $48.00 Per Share	NASDAQ:CHIR	Chiron (MM)
30/03/2006	23:45	Business Wire	Chiron Statement on Recommendations by Proxy Advisory Services	NASDAQ:CHIR	Chiron (MM)
16/03/2006	08:00	Business Wire	Chiron Recalls and Withdraws MORUPAR(R) MMR Vaccine from Italian and Developing World Markets -- Chiron Also Revises 2005 Adjus	NASDAQ:CHIR	Chiron (MM)
15/03/2006	15:27	Business Wire	Chiron Response to ValueAct Letter	NASDAQ:CHIR	Chiron (MM)
02/03/2006	12:30	Business Wire	CORRECTING and REPLACING Chiron Schedules Special Meeting of Stockholders to Approve Merger With Novartis	NASDAQ:CHIR	Chiron (MM)
02/03/2006	07:30	Business Wire	Chiron Schedules Special Meeting of Stockholders to Approve Merger With Novartis	NASDAQ:CHIR	Chiron (MM)
24/02/2006	15:02	Business Wire	Chiron Confirms Proposed Purchase of BETASERON Assets by Schering AG Under Change-in-Control Option	NASDAQ:CHIR	Chiron (MM)
24/02/2006	15:01	Business Wire	Chiron Announces Pandemic Influenza Vaccine Contract with the UK Government; Chiron Submits Pandemic Influenza Vaccine ``Mock-U	NASDAQ:CHIR	Chiron (MM)
24/02/2006	15:01	Business Wire	Chiron Updates Delivery Expectations for U.S. Government H5N1 Vaccine Stockpile Contract	NASDAQ:CHIR	Chiron (MM)
07/02/2006	07:00	Business Wire	Chiron Announces Termination of SEC Investigation	NASDAQ:CHIR	Chiron (MM)
06/02/2006	20:00	Business Wire	Chiron Receives European Commission Approval for Proposed Merger With Novartis	NASDAQ:CHIR	Chiron (MM)
02/02/2006	07:00	Business Wire	Chiron Foundation Awards Grants to National Organizations Promoting Improved Quality of Life for Cancer and Lung Transplant Pati	NASDAQ:CHIR	Chiron (MM)
31/01/2006	15:01	Business Wire	Chiron Reports 2005 Adjusted Earnings of $1.34 Per Share, GAAP Earnings of $0.97 Per Share; FLUVIRIN(R) Influenza Virus Vaccine	NASDAQ:CHIR	Chiron (MM)
23/01/2006	15:33	Business Wire	Cubicin(R) Granted Marketing Approval in Europe; First-in-Class Antibiotic Approved for Treatment of Complicated Skin and Soft-T	NASDAQ:CHIR	Chiron (MM)
23/01/2006	15:00	PR Newswire (US)	ArcaEx Tech 100 Index(R) Announces Change to Index Components	NASDAQ:CHIR	Chiron (MM)
17/01/2006	07:00	Business Wire	Chiron to Release Earnings on Tuesday, January 31, 2006; Conference Call/Audio Webcast to Follow	NASDAQ:CHIR	Chiron (MM)
05/01/2006	07:00	Business Wire	Chiron to Present at 24th Annual JPMorgan Healthcare Conference	NASDAQ:CHIR	Chiron (MM)
05/01/2006	07:00	Business Wire	Chiron Foundation Awards Grants to Seven Organizations Committed to Fighting Global Health Threats	NASDAQ:CHIR	Chiron (MM)
31/10/2005	04:02	Business Wire	Chiron Announces Merger Agreement with Novartis; Novartis to Acquire Outstanding 58 Percent of Chiron Shares for $45.00 Per Shar	NASDAQ:CHIR	Chiron (MM)
28/10/2005	08:00	Business Wire	Chiron Announces Promising Data from Clinical Study of Adjuvanted Avian Influenza Vaccine; Results Confirm Previous Clinical Stu	NASDAQ:CHIR	Chiron (MM)
27/10/2005	12:46	Business Wire	Chiron to Supply United States with Pandemic Influenza Vaccine for Stockpile; Contract with U.S. Department of Health & Human Se	NASDAQ:CHIR	Chiron (MM)
25/10/2005	15:00	Business Wire	Chiron Reports Third-Quarter 2005 Adjusted Earnings of $0.38 per Share, GAAP Earnings of $0.27 per Share	NASDAQ:CHIR	Chiron (MM)
25/10/2005	08:00	Business Wire	Chiron Initiates U.S. Phase I/II Study of Influenza Cell Culture Vaccine	NASDAQ:CHIR	Chiron (MM)